GLI1 and pancreatic neoplasm: With an increased application of massive parallel sequencing of whole cancer genomes, more mutations in GLI1 and GLI3 have been discovered in breast, colorectal, pancreatic cancers and soft-tissue sarcomas [156,157,158,159].